Company
KALA BIO
KALA BIO is a biopharmaceutical company on a mission.
Also known as KALA BIO, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- enterprise applications in the biopharmaceutical industry
- Legal name
- KALA BIO, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
KALA BIO is focused on understanding its legacy research, the science behind its prior ophthalmic programs, and the value of the clinical data it has already collected.
Funding snapshot
- Total raised
- $159MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $1.8M2026-03-03
Funding rounds
- Round, 2026
- $1.8M2026-03-03, SEC form D sold, 1 investor
- Round, 2026
- $2.3M2026-01-30, SEC form D sold, 20 investors
- Round, 2024
- $10.7M2024-12-31, SEC form D sold, 6 investors
- Round, 2024
- $12.5M2024-06-28, SEC form D sold, 5 investors
- Round, 2021
- $16.1M2021-11-15, SEC form D sold, 26 investors
- Round, 2016
- $67.9M2016-04-06, SEC form D sold, 25 investors
- Round, 2015
- $7M2015-08-17, SEC form D sold, 1 investor
- Round, 2014
- $22.5M2014-04-16, SEC form D sold, 16 investors
- Round, 2013
- $5.8M2013-02-14, SEC form D sold, 10 investors
- Round, 2012
- $7.2M2012-02-29, SEC form D sold, 10 investors
- Round, 2010
- $3M2010-10-26, SEC form D sold, 9 investors
- Round, 2009
- $2M2009-12-11, SEC form D sold, 10 investors
Loading relationship preview